The National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study (REDS‐III): a research program striving to improve blood donor and transfusion recipient outcomes

The Recipient Epidemiology and Donor Evaluation Study‐III (REDS‐III) is a 7‐year multicenter transfusion safety research initiative launched in 2011 by the National Heart, Lung, and Blood Institute.

[1]  B. Custer,et al.  Undisclosed human immunodeficiency virus risk factors identified through a computer‐based questionnaire program among blood donors in Brazil , 2013, Transfusion.

[2]  M. Busch,et al.  Comparison of human immunodeficiency virus assays in window phase and elite controller samples: viral load distribution and implications for transmission risk , 2013, Transfusion.

[3]  D. Wright,et al.  An analysis of risk factors for human immunodeficiency virus infection among Chinese blood donors , 2013, Transfusion.

[4]  S. Glynn,et al.  Restless legs syndrome, pica, and iron status in blood donors , 2013, Transfusion.

[5]  B. Custer,et al.  Risk factors for human immunodeficiency virus infection among Brazilian blood donors: a multicentre case–control study using audio computer‐assisted structured interviews , 2013, Vox sanguinis.

[6]  C. L. Oliveira,et al.  HIV Genotypes and Primary Drug Resistance Among HIV-Seropositive Blood Donors in Brazil: Role of Infected Blood Donors as Sentinel Populations for Molecular Surveillance of HIV , 2013, Journal of acquired immune deficiency syndromes.

[7]  J. Pathak,et al.  Electronic health record surveillance algorithms facilitate the detection of transfusion‐related pulmonary complications , 2013, Transfusion.

[8]  D. Wright,et al.  Prevalence, incidence, and residual risks for transfusion‐transmitted human immunodeficiency virus Types 1 and 2 infection among Chinese blood donors , 2013, Transfusion.

[9]  K. King,et al.  Red blood cell alloimmunization: lessons from sickle cell disease , 2013, Transfusion.

[10]  E. Murphy,et al.  Risk factors and outcomes in transfusion-associated circulatory overload. , 2013, The American journal of medicine.

[11]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[12]  S. Glynn,et al.  The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability. , 2012, Transfusion medicine reviews.

[13]  Marion C Lanteri,et al.  Dengue in the context of “safe blood” and global epidemiology: to screen or not to screen? , 2012, Transfusion.

[14]  R. Ware,et al.  Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. , 2012, Blood.

[15]  G. Rutherford,et al.  Acquisition of GB virus type C and lower mortality in patients with advanced HIV disease. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  J. A. Hopkins,et al.  Iron replacement therapy in the routine management of blood donors , 2012, Transfusion.

[17]  S. Obaro.  Does sickle cell disease protect against HIV/AIDS? , 2012, Sexually Transmitted Infections.

[18]  S. Glynn,et al.  Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century , 2012, Transfusion.

[19]  S. Glynn,et al.  The human immunodeficiency virus‐1 genotype diversity and drug resistance mutations profile of volunteer blood donors from Chinese blood centers , 2012, Transfusion.

[20]  G. Rutherford,et al.  Transmission of GB virus type C via transfusion in a cohort of HIV-infected patients. , 2012, The Journal of infectious diseases.

[21]  L. Hofbauer,et al.  The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes. , 2012, Leukemia research.

[22]  S. Glynn,et al.  Iron deficiency in blood donors: the REDS‐II Donor Iron Status Evaluation (RISE) study , 2012, Transfusion.

[23]  B. Custer,et al.  Human immunodeficiency virus prevalence, incidence, and residual risk of transmission by transfusions at Retrovirus Epidemiology Donor Study‐II blood centers in Brazil , 2012, Transfusion.

[24]  M. Popovsky,et al.  Anemia, iron depletion, and the blood donor: it's time to work on the donor's behalf , 2012, Transfusion.

[25]  J. de Wildt-Eggen,et al.  Hemolysis of red blood cells during processing and storage , 2012, Transfusion.

[26]  R. Weiskopf,et al.  Transfusion-related acute lung injury: incidence and risk factors. , 2012, Blood.

[27]  N. Jahanshad,et al.  Brain structure in healthy adults is related to serum transferrin and the H63D polymorphism in the HFE gene , 2012, Proceedings of the National Academy of Sciences.

[28]  Z. Bi,et al.  Person-to-Person Transmission of Severe Fever With Thrombocytopenia Syndrome Bunyavirus Through Blood Contact , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  D. Devine,et al.  Deferral of males who had sex with other males , 2011, Vox sanguinis.

[30]  William Buhles.  A novel bunyavirus in China. , 2011, The New England journal of medicine.

[31]  X. Qi,et al.  A novel bunyavirus in China. , 2011, The New England journal of medicine.

[32]  K. Langa,et al.  Utilization of blood transfusion among older adults in the United States , 2011, Transfusion.

[33]  E. Bunnik,et al.  Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level , 2010, Nature Medicine.

[34]  B. Custer,et al.  Demographic correlates of low hemoglobin deferral among prospective whole blood donors , 2010, Transfusion.

[35]  S. Glynn,et al.  The red blood cell storage lesion: a method to the madness , 2010, Transfusion.

[36]  W. Mcfarland,et al.  Human immunodeficiency virus test‐seeking blood donors in a large blood bank in São Paulo, Brazil , 2010, Transfusion.

[37]  T. Pieber,et al.  Apheresis affects bone and mineral metabolism. , 2010, Bone.

[38]  V. Deneys,et al.  The blood donor in sub‐Saharan Africa: a review , 2010, Transfusion medicine.

[39]  Gonçalo Abecasis,et al.  Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels , 2009, Nature Genetics.

[40]  Ian H. Frazer,et al.  Common variants in TMPRSS6 are associated with iron status and erythrocyte volume , 2009, Nature Genetics.

[41]  C. Hillyer,et al.  The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion‐related acute lung injury risk reduction strategy , 2009, Transfusion.

[42]  S. Anderson,et al.  Blood use in the ambulatory setting among elderly in the United States , 2009, Transfusion.

[43]  L. Grummer-Strawn,et al.  Assessment of iron deficiency in US preschool children and nonpregnant females of childbearing age: National Health and Nutrition Examination Survey 2003-2006. , 2009, The American journal of clinical nutrition.

[44]  M. Melbye,et al.  Post‐transfusion mortality among recipients of ABO‐compatible but non‐identical plasma , 2009, Vox sanguinis.

[45]  AK Hamilton,et al.  Maternal mortality in sub‐Saharan Africa: the contribution of ineffective blood transfusion services , 2009, BJOG : an international journal of obstetrics and gynaecology.

[46]  I. Bates,et al.  Maternal mortality in sub‐Saharan Africa: the contribution of ineffective blood transfusion services , 2008, BJOG : an international journal of obstetrics and gynaecology.

[47]  H. Dickhuth,et al.  Recovery of hemoglobin mass after blood donation , 2008, Transfusion.

[48]  R. Lanciotti,et al.  Dengue viremia in blood donors from Honduras, Brazil, and Australia , 2008, Transfusion.

[49]  B. Beutler,et al.  The Serine Protease TMPRSS6 Is Required to Sense Iron Deficiency , 2008, Science.

[50]  R. Mendoza-Sassi,et al.  [High prevalence of users who did not return to the Testing and Counseling Center (TCC) for knowing their serological status: Rio Grande, RS, Brazil]. , 2008, Ciencia & saude coletiva.

[51]  Gabriel J. Escobar,et al.  Risk-Adjusting Hospital Inpatient Mortality Using Automated Inpatient, Outpatient, and Laboratory Databases , 2008, Medical care.

[52]  Lisa M. Schwartz,et al.  A genetic risk factor for periodic limb movements in sleep. , 2008, The New England journal of medicine.

[53]  L. Wideroff,et al.  Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study , 2007, The Lancet.

[54]  C. Hillyer,et al.  Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines. , 2007, Transfusion medicine reviews.

[55]  M Reilly,et al.  A population‐based binational register for monitoring long‐term outcome and possible disease concordance among blood donors and recipients , 2006, Vox sanguinis.

[56]  A. Lalonde,et al.  Postpartum hemorrhage today: ICM/FIGO initiative 2004–2006 , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[57]  K. Chaloner,et al.  Effect of early and late GB virus C viraemia on survival of HIV‐infected individuals: a meta‐analysis , 2006, HIV medicine.

[58]  S. Glynn,et al.  A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors , 2005, Transfusion.

[59]  D. Gubler,et al.  Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses , 2004, Nature Medicine.

[60]  S. Brunskill,et al.  Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials , 2004, British journal of haematology.

[61]  S. Wünschmann,et al.  Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MlP-lα, MIP-1β, and SDF-1 , 2004, The Lancet.

[62]  A. Brand,et al.  HLA and RBC immunization after filtered and buffy coat‐depleted blood transfusion in cardiac surgery: a randomized controlled trial , 2003, Transfusion.

[63]  Diane deConing.  Challenges Facing Donor Recruitment in South Africa , 2002, Vox sanguinis.

[64]  S. Leitman,et al.  Comprehensive analysis of citrate effects during plateletpheresis in normal donors , 2001, Transfusion.

[65]  C. Nass,et al.  The Retrovirus Epidemiology Donor Study (REDS): rationale and methods , 1995, Transfusion.

[66]  J. Delaunay.  The molecular basis of hereditary red cell membrane disorders. , 2007, Blood reviews.

[67]  J. Stapleton,et al.  Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. , 2004, Lancet.

[68]  N. Michael,et al.  Joint United Nations Programme on HIV/AIDS. , 2004, Military medicine.

[69]  George S. Ansell,et al.  Co-Principal Investigators: , 1984 .

[70]  Iron deficiency in the United States. , 1968, JAMA.